Solicitation of the Nomination of Candidates To Serve as Members of the National Vaccine Advisory Committee, 49620-49621 [05-16762]

Download as PDF 49620 Federal Register / Vol. 70, No. 163 / Wednesday, August 24, 2005 / Notices Trans # Acquiring Acquired Entities Transactions Granted Early Termination—08/03/2005 20051341 ......................... Department 56, Inc ............................ Brown-Forman Corporation ............... Lenox, Incorporated. Transactions Granted Early Termination—08/04/2005 20051253 ......................... 20051268 ......................... Integrated Device Technology, Inc ... Entergy Corporation .......................... Integrated Circuit Systems, Inc ......... Attala 2004 Trust ............................... 20051303 ......................... 20051316 ......................... Omnicare, Inc .................................... New Refco Group Ltd., LLC .............. excelleRx, Inc .................................... Cargill Incorporated ........................... Integrated Circuit Systems, Inc. Central Mississippi Generating Company, LLC excelleRx, Inc. Cargill Investor Services, Inc., Cargill Investor Services Limited, Cargill Investor Services (Singapore) Pte. Ltd., CIS Cash Management, Inc., CIS Financial Services, Inc., CIS Investments, Inc., CIS Securities, Inc. Transactions Granted Early Termination—08/05/2005 20051308 20051329 20051330 20051336 ......................... ......................... ......................... ......................... Cemex S.A. de C.V. .......................... Stefan Pierer ..................................... Rudolf Knunz ..................................... Pharma Services Holding, Inc ........... 20051337 ......................... 20051344 ......................... 20051346 ......................... Greene Group, Inc ............................ Polaris Industries Inc ......................... Polaris Industries Inc ......................... Welsch, Carson, Anderson & Stowe X, L.P. WMB Holdings Inc ............................. Perot Systems Corporation ............... Sagicor Financial Corporation ........... 20051349 ......................... 20051353 ......................... 20051358 ......................... Cisco Systems, Inc ............................ BNP Paribas S.A ............................... Fiserv, Inc .......................................... 20051364 ......................... 20051368 ......................... Business Objects S.A ........................ Barry Diller ......................................... Sheer Networks Inc ........................... FundQuest Incorporated ................... Great Hill Equity Partners II Limited Partnership. Trevor Lloyd ...................................... Barry Diller ......................................... For Further Information Contact: Sandra M. Peay, Contact Representative or Renee Hallman, Case Management Assistant. Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H–303, Washington, DC 20580, (202) 326–3100. By Direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 05–16778 Filed 8–23–05; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation of the Nomination of Candidates To Serve as Members of the National Vaccine Advisory Committee AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. Authority: 42 U.S.C. 300aa–5, Section 2105 of the Public Health Service (PHS) Act, as amended. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets VerDate jul<14>2003 15:23 Aug 23, 2005 Jkt 205001 CityBank ............................................ Ronald J. Lockard ............................. Vesta Insurance Group, Inc .............. forth standards for the formation and use of advisory committees. SUMMARY: The National Vaccine Program Office (NVPO), a program office within the Office of Public Health and Science, DHHS, is soliciting nominations of qualified candidates to be considered for appointment as members and representatives to the National Vaccine Advisory Committee (NVAC). The activities of this Committee are governed by the Federal Advisory Committee Act (FACA). Consistent with the National Vaccine Plan, the Committee advises and makes recommendations to the Assistant Secretary for Health in his/her capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Specifically, the Committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States; recommends research priorities and other measures to enhance the safety and efficacy of vaccines. The Committee also advises the Assistant Secretary for Health in the implementation of Sections 2102 and 2103 of the PHS Act; and identifies annually the most important areas of PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 RMC Mid-Atlantic, LLC. KTM Power Sports AG KTM Power Sports AG. Early Development and Packaging Services, USA, L.L.C. Diligenz, Inc. Technical Management, Inc. American Founders Financial Corporation, Laurel Life Insurance Company. Sheer Networks Inc. FundQuest Incorporated. BillMatrix Corporation. SRC Software, Inc. Expedia, Inc. government and non-government cooperation that should be considered in implementing Sections 2102 and 2103 of the PHS Act. DATES: Nominations for membership on the Committee must be received no later than 5 p.m. EST on October 3, 2005, at the address below. ADDRESSES: All nominations should be mailed or delivered to Bruce G. Gellin, M.D., M.P.H., Executive Secretary, National Vaccine Advisory Committee, Office of Public Health and Science, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Hubert H. Humphrey Building; Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, National Vaccine Program Office, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443–H, Hubert H. Humphrey Building, Washington, DC 20201; (202) 690–5566; nvac@osophs.dhhs.gov. A copy of the Committee charter and list of the current membership can be obtained by contacting Ms. English or by accessing the NVAC Web site at: https://www.hhs.gov/nvpo/nvac. SUPPLEMENTARY INFORMATION: E:\FR\FM\24AUN1.SGM 24AUN1 Federal Register / Vol. 70, No. 163 / Wednesday, August 24, 2005 / Notices Committee Function: Qualifications and Information Required: As part of an ongoing effort to enhance deliberations and discussions with the public on vaccine and immunization policy, nominations are being sought for interested individuals to serve on the Committee. Individuals selected for appointment to the Committee will serve as voting members or representatives. Voting members shall be selected from individuals who are engaged in vaccine research or the manufacture of vaccines, or who are physicians, members of parent organizations concerned with immunizations, representatives of State or local health agencies or public health organizations. Voting representatives are official representatives of the vaccine manufacturing industry who are engaged in vaccine research or the manufacture of vaccines. Individuals selected for appointment to the Committee can be invited to serve terms with periods of up to four years. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as a member of the Committee; (2) the nominator’s name, address and daytime telephone number, and the home and/ or work address, telephone number, and email address of the individual being nominated; and (3) a current copy of the nominee’s curriculum vitae. Applications cannot be submitted by facsimile. The names of Federal employees should not be nominated for consideration of appointment to this Committee. The Department makes every effort to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Every effort is made that a broad representation of geographic areas, gender, ethnic and minority groups, and the disabled are given consideration for membership on HHS Federal advisory committees. Appointment to this committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. VerDate jul<14>2003 15:23 Aug 23, 2005 Jkt 205001 Dated: August 18, 2005. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. 05–16762 Filed 8–23–05; 8:45 am] BILLING CODE 4150–44–P 49621 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–05–0106] DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration on Aging 2005 White House Conference on Aging Policy Committee AGENCY: Administration on Aging, HHS. ACTION: Notice of meeting. SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2), notice is hereby given of the seventh Policy Committee meeting concerning planning for the 2005 White House Conference on Aging. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the contact person listed below in advance of the meeting. DATES: The meeting will be held Tuesday, September 20, 2005, from 10 a.m. to 4:30 p.m. ADDRESSES: The meeting will be held in the Atrium Ballroom at The Washington Court Hotel, 525 New Jersey Avenue, NW., Washington, DC 20001–1527. FOR FURTHER INFORMATION CONTACT: Kim Butcher at (301) 443–2887, or e-mail at Kim.Butcher@whcoa.gov. Registration is not required. Seating is on a first come, first-served basis. SUPPLEMENTARY INFORMATION: Pursuant to the Older Americans Act Amendments of 2000 (Pub. L. 106–501, November 2000), the Policy Committee will meet to continue discussions and planning for the 2005 WHCoA that will be held from December 11 through 14, 2005. In addition, there will be presentations by Brent Green, President of Brent Green & Associates, Inc., a marketing consulting firm, and author of Marketing to Leading Edge Baby Boomers and David G. Walker, Comptroller General, U.S. Government Accountability Office. Dated: August 19, 2005. Edwin L. Walker, Deputy Assistant Secretary for Policy and Programs. [FR Doc. 05–16829 Filed 8–23–05; 8:45 am] BILLING CODE 4154–01–P PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 Proposed Data Collections Submitted for Public Comment and Recommendations The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 371–5983 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Preventive Health and Health Services Block Grant, Annual Application and Reports, OMB No. 0920–0106— Revision—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description In 1994, OMB approved the collection of information provided in the grant applications and annual reports for the Preventive Health and Health Services (PHHS) Block Grant (OMB No. 0920– 0106). CDC is requesting OMB clearance for this legislatively mandated information collection. The request is to approve the development and adherence to Healthy People 2010 (the Nation’s Health Objectives) which was released in the Spring of 2000. The PHHS block grant is mandated according to section 1904 to adhere to the Healthy People framework. This information, which is collected through the application forms from the official State health agencies, is required from section 1905 of the Public Health Service Act. There is a slight change in the proposed information collection from previous years. The changes include more program specific information and the relationship of block funded activities to program strategy. The information collected from the annual report forms is required by section 1906. The development of a PHHS block grant Web page, with data Web links from existing federal databases, will be used to coincide with the collection of uniform data for the E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 70, Number 163 (Wednesday, August 24, 2005)]
[Notices]
[Pages 49620-49621]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16762]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of the Nomination of Candidates To Serve as Members 
of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health 
Service (PHS) Act, as amended. The Committee is governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), 
which sets forth standards for the formation and use of advisory 
committees.

SUMMARY: The National Vaccine Program Office (NVPO), a program office 
within the Office of Public Health and Science, DHHS, is soliciting 
nominations of qualified candidates to be considered for appointment as 
members and representatives to the National Vaccine Advisory Committee 
(NVAC). The activities of this Committee are governed by the Federal 
Advisory Committee Act (FACA).
    Consistent with the National Vaccine Plan, the Committee advises 
and makes recommendations to the Assistant Secretary for Health in his/
her capacity as the Director of the National Vaccine Program, on 
matters related to the Program's responsibilities. Specifically, the 
Committee studies and recommends ways to encourage the availability of 
an adequate supply of safe and effective vaccination products in the 
United States; recommends research priorities and other measures to 
enhance the safety and efficacy of vaccines. The Committee also advises 
the Assistant Secretary for Health in the implementation of Sections 
2102 and 2103 of the PHS Act; and identifies annually the most 
important areas of government and non-government cooperation that 
should be considered in implementing Sections 2102 and 2103 of the PHS 
Act.

DATES: Nominations for membership on the Committee must be received no 
later than 5 p.m. EST on October 3, 2005, at the address below.

ADDRESSES: All nominations should be mailed or delivered to Bruce G. 
Gellin, M.D., M.P.H., Executive Secretary, National Vaccine Advisory 
Committee, Office of Public Health and Science, Department of Health 
and Human Services, 200 Independence Avenue, SW., Room 443-H, Hubert H. 
Humphrey Building; Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, 200 Independence Avenue, SW., Room 443-H, Hubert H. Humphrey 
Building, Washington, DC 20201; (202) 690-5566; nvac@osophs.dhhs.gov.
    A copy of the Committee charter and list of the current membership 
can be obtained by contacting Ms. English or by accessing the NVAC Web 
site at: https://www.hhs.gov/nvpo/nvac.

SUPPLEMENTARY INFORMATION:

[[Page 49621]]

    Committee Function: Qualifications and Information Required: As 
part of an ongoing effort to enhance deliberations and discussions with 
the public on vaccine and immunization policy, nominations are being 
sought for interested individuals to serve on the Committee. 
Individuals selected for appointment to the Committee will serve as 
voting members or representatives. Voting members shall be selected 
from individuals who are engaged in vaccine research or the manufacture 
of vaccines, or who are physicians, members of parent organizations 
concerned with immunizations, representatives of State or local health 
agencies or public health organizations. Voting representatives are 
official representatives of the vaccine manufacturing industry who are 
engaged in vaccine research or the manufacture of vaccines. Individuals 
selected for appointment to the Committee can be invited to serve terms 
with periods of up to four years.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e., specific attributes which qualify the nominee for 
service in this capacity), and a statement that the nominee is willing 
to serve as a member of the Committee; (2) the nominator's name, 
address and daytime telephone number, and the home and/or work address, 
telephone number, and email address of the individual being nominated; 
and (3) a current copy of the nominee's curriculum vitae. Applications 
cannot be submitted by facsimile. The names of Federal employees should 
not be nominated for consideration of appointment to this Committee.
    The Department makes every effort to ensure that the membership of 
HHS Federal advisory committees is fairly balanced in terms of points 
of view represented and the committee's function. Every effort is made 
that a broad representation of geographic areas, gender, ethnic and 
minority groups, and the disabled are given consideration for 
membership on HHS Federal advisory committees. Appointment to this 
committee shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.

    Dated: August 18, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05-16762 Filed 8-23-05; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.